Strategy and product
The benefit hypothesis
Which problem should be solved better for which target group, and which assumptions support the positioning?
Product adoption in healthcare
Adoption happens in routine care.
A product has not been adopted merely because there is interest or a contract has been signed. It becomes routine when benefit, decision-making, financing, workflow, trust and learning fit together.
Professional experiencePharma and business development
Current contextFive practice sites
Care settingGerman outpatient market
FocusFrom concept to routine
Adoption gates
Six gates determine whether interest becomes routine use.
Adoption is not a single stage in a commercial funnel. Every gate can slow a product down or reveal what still needs to be resolved before broader implementation.
Does the product solve a sufficiently important problem?
Define the problem, target group and intended benefit from the care-delivery perspective instead of starting with features or market size.
What actually becomes better for patients or teams?Who says yes — and who must work with it afterwards?
Purchase, prescription, use, financing and operational accountability may sit with different actors.
Are decision-makers, users and effort-bearers the same?Is use financially and contractually possible?
Assess reimbursement, budgets, contracts, investment, ongoing effort and provider-side economic risk together.
Does a viable operating model remain after initial interest?Does the product fit the real patient pathway?
Test time, rooms, staff, IT, documentation, materials, handoffs and exceptions down to concrete work steps.
Where does new work or a new constraint emerge?Do people understand the benefit, risk and change?
Address evidence, training, clinical accountability, objections and patient communication before rather than after the purchase decision.
What enables responsible use?Can implementation generate reliable learning?
Define the pilot objective, measures, feedback route, stopping criteria and requirements for expansion before starting.
Which evidence justifies the next scaling step?
Decision system
Adoption has no single decision-maker.
In outpatient care, approval, budget, accountability and daily work often sit at different levels. A viable strategy connects these perspectives.
Access and financing
The conditions for use
Under which regulatory, contractual and economic conditions is use realistic?
Clinical decision
Professional accountability
Which evidence, indication, safety and clinical judgment are required for responsible use?
Organization and routine
Actual implementation
Which teams, workflows, systems, information and feedback make routine use reliable?
Product realities
Three product types, three different adoption logics.
The six gates remain the same. Their practical meaning changes with the product, accountability and care pathway.
Price and reimbursement are not enough.
Clinical fit, availability, contracts, switching processes and communication can determine whether use is responsible.
- clinical assessment and selection
- availability and contracting conditions
- switching and patient communication
Technical performance must connect to the operating model.
Investment, space, utilization, training, service, materials and process time help determine whether a device or procedure works economically and practically.
- capacity and patient volume
- workflow, qualification and service
- investment and ongoing operation
More features do not yet create relief.
Integration into information flows, IT, accountability and privacy review determines whether a solution reduces work or creates parallel processes.
- measurable benefit in the workflow
- data flow and system integration
- operation, support and accountability
False shortcuts
Four shortcuts that only appear to accelerate adoption.
These patterns look efficient at first, but move unresolved questions into implementation, where corrections are usually more expensive and difficult.
A solution searches for its problem.
Features and technology are explained before a concrete care problem and affected target group are properly understood.
The contract is mistaken for use.
Formal approval says little about whether clinical decision-makers, teams and patients can sustain the change in daily care.
Additional work remains invisible.
Training, documentation, coordination, exceptions and support are omitted from the economic and operational assessment.
The pilot has no scaling rule.
Without target values, a feedback route and explicit criteria, a pilot remains an observation rather than a robust learning phase.
Concrete work products
Move from assumption to a decision-ready view.
Different analytical outputs are useful at different starting points. They separate evidence, assumptions, open questions and the next review steps.
Adoption hypothesis
Connect problem, target group, benefit, decision-makers, users and central risks in a testable logic.
View the advisory approachCare-delivery and stakeholder map
Make the patient pathway, decision levels, financing, workload and feedback loops visible.
Explore the care systemImplementation brief
Prepare prerequisites, pilot scope, accountability, measures and the scaling decision in a structured way.
Explore the decision frameworkSector-specific assessment
In ophthalmology, consider product, treatment pathway, reimbursement and practice operations together.
Explore ophthalmology
Selected perspectives
Explore adoption from four angles.
The contributions show how price, strategy, digitalization and operational workflows shape actual use.
Ophthalmic biosimilars: the lowest price does not yet create successful care
Biosimilars can strengthen competition and reduce pharmaceutical spending. In intravitreal care, however, clinical fit, availability, contracts, operations and patient communication matter alongside price.
View contributionGood healthcare strategies rarely fail because of the idea — they fail in implementation
A convincing strategy only becomes robust when roles, workflows, incentives and feedback from care delivery are considered. Why the real work begins after the decision.
View contributionDigitalization in outpatient care: Benefit before features
Why digital solutions should begin with a clear care delivery problem and measurable benefit rather than with features.
View contributionSurgery does not begin in the operating room
Operating time is only one part of an outpatient procedure. Patient selection, preoperative assessment, informed consent, materials, hygiene, staffing, documentation and follow-up determine whether an operating day works safely and reliably.
View contributionWorking material
Download the decision check
Prepare the next review point systematically.
The Healthcare Advisory decision check helps structure the question, evidence, care-delivery reality, risks and intended outcome before a conversation.
German-language PDF · 9 pagesClear boundary
Care-delivery and implementation analysis, not individual advice.
The content addresses market, product, organizational and implementation questions. It does not replace individual medical, legal, regulatory, tax or binding reimbursement advice. Medical decisions remain physician responsibilities. Confidential documents and patient data do not belong in an initial enquiry.
Test a product or adoption question realistically
Briefly describe the product, target group, intended use and current decision. This makes it possible to identify which adoption gate offers the greatest learning value.